PharmiWeb1h
Roche receives FDA clearance with CLIA waiver for cobas® liat molecular tests to diagnose sexually transmitted infections at the point of care
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance and Clinical Laboratory Improvement Amendments of 1988 (CLIA) waiver ...
New tests at GP clinics aim to reduce antibiotic use and fight antimicrobial resistance
Does your infection require antibiotics? Two tests are being trialled to remove the guesswork for GPs and confirm whether a ...
Expert Discovery: Oyster Blood Protein Could Revolutionize Fight Against Antibiotic-Resistant Superbugs
Researchers uncover a protein in Australian oyster blood that boosts antibiotic effectiveness and fights superbugs, offering ...